Through this new partnership, WFAM will be even better positioned to execute our strategy and provide our clients with innovative solutions to help them reach their investment goals, wrote Jim Hays, head of Wells Fargo Advisors, and Nico Marais, CEO of Wells Fargo Asset Management
Stubborn fat deposits that resist diet and exercise, difficulty with body recomposition, patients on a weight management program who want additional metabolic support, and those seeking fat-targeted peptide therapy without broad hormonal effects
How Do You Choose Between Metformin and Ozempic
The most common side effects are stomach-related: nausea, diarrhea, vomiting, and constipation, especially during dose escalation
Semaglutide was extensively tested in several phase 3 trials for its therapeutic potential, including as part of the Semaglutide Treatment Effect in People with Obesity (STEP) and Semaglutide Unabated Sustainability in Treatment of Type 2 Diabetes (SUSTAIN) clinical programs